One dynamic that we and investors will be closely monitoring is the potential tailwind to branded GLP-1 drugs for obesity when compounded versions can no longer be sold in the US, as of May 22, 2025
Targeting tumor Gln metabolism has emerged as a prominent focus in tumor metabolic therapy
There is only level 4 evidence on partial or interstitial rotator cuff tears or cuff tendonopathy, these being small case series
For estimation purposes, similar to the assumptions previously used for the STEMI and Excessive Radiation Dose or Inadequate Image Quality for Diagnostic CT in Adults eCQMs, we estimate 20 percent of HOPDs will voluntarily report one quarter of data for the measure in the CY 2027 reporting period, with 100 percent of HOPDs reporting the measure as required in subsequent years (86 FR 63962 and 63963, and 88 FR 82134)
Back Molteni, M (17 Oct 2023) 'How one scientist's determination made Novo Nordisk an obesity-drug powerhouse', STAT News
3b), we estimated the enterocyte maturity score by averaging the expression levels of enterocyte genes that increase with age (Supplementary Table 3)
